Hepatorenalt syndrom: diagnose, behandling og forebyggelse

Mads Egerod Israelsen, Lise Lotte Gluud, Flemming Bendtsen, Søren Møller, Aleksander Ahm Krag

1 Citationer (Scopus)

Abstract

Cirrhosis, ascites and renal impairment are associated with high morbidity and mortality. The hepatorenal syndrome (HRS) is a type of renal failure that affects patients with cirrhosis and ascites. This paper provides an update on evidence-based interventions in HRS. A number of factors can precipitate HRS. The monitoring, prevention, early detection, and correct treatment of these are essential. Terlipressin combined with albumin is the first-line treatment of type 1 HRS. In type 2 HRS with refractory ascites, liver transplantation and TIPS should be considered.
Bidragets oversatte titelHepatorenal syndrome: diagnosis, treatment and prevention
OriginalsprogDansk
TidsskriftUgeskrift for Laeger
Vol/bind175
Udgave nummer22
Sider (fra-til)1562-6
Antal sider5
ISSN0041-5782
StatusUdgivet - 27 maj 2013

Emneord

  • Albumins
  • Ascites
  • Drug Therapy, Combination
  • Evidence-Based Medicine
  • Hepatorenal Syndrome
  • Humans
  • Kidney
  • Liver Cirrhosis
  • Liver Transplantation
  • Lypressin
  • Portasystemic Shunt, Transjugular Intrahepatic
  • Vasoconstrictor Agents

Fingeraftryk

Dyk ned i forskningsemnerne om 'Hepatorenalt syndrom: diagnose, behandling og forebyggelse'. Sammen danner de et unikt fingeraftryk.

Citationsformater